In this study, we tested the hypothesis that a similar form of delivery of other IL-10-inducing immunoregulatory small molecule, such as curcumin, ameliorates chronic inflammation in two CID mouse models (atherosclerosis and experimental autoimmune encephalomyelitis, EAE) via immune system regulation. The gene discussed is IL10; the disease is combined immunodeficiency.